Clinical Trial Update: Total Body Irradiation and Cladribine Before Allogeneic Hematopoietic Cell Transplantation in Patients With AML (Acute Myeloid Leukemia) and Myelodysplastic Syndromes [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating total body irradiation and cladribine as conditioning before allogeneic hematopoietic cell transplantation in patients wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Cladribine (cladribine)

Snippet

Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology | Conditions: Acute Myeloid Leukemia Myelodysplastic Syndromes | Phase 2 | Status: ACTIVE_NOT_RECRUITING